Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2023 Jul 31;7(9):101985.
doi: 10.1016/j.cdnut.2023.101985. eCollection 2023 Sep.

Lysophosphatidylcholine-Rich Nutrition Therapy Increased Gut Absorption of Coingested Dietary Fat: a Randomized Controlled Trial

Alyssa Tindall  1 , Maria Mascarenhas  1   2 , Asim Maqbool  1   2 , Virginia A Stallings  1   2
Affiliations
Case Reports

Lysophosphatidylcholine-Rich Nutrition Therapy Increased Gut Absorption of Coingested Dietary Fat: a Randomized Controlled Trial

Alyssa Tindall et al. Curr Dev Nutr. .

Erratum in

Abstract

Unintentional weight loss is common in persons with chronic and acute disease and is often caused by insufficient intake or malabsorption. A new lysophosphatidylcholine (LPC)-rich structured lipid powder has micelle-like activity that facilitates digestion and absorption, independent of lipase and bile acids. The aim of this secondary analysis was to determine if recycled LPC increased fat absorption of coingested food. Fasting plasma fatty acid (FA) concentrations were measured at baseline and 3 mo in children (n = 84) with cystic fibrosis and pancreatic insufficiency. Plasma palmitic acid was selected because of its dietary prevalence and was a minor component of the LPC product. Palmitic acid increased 15% in the LPC product-treated total subjects (P = 0.01) and 23% in the subgroup with more severe malabsorption (P = 0.007), with no change in either group on placebo. Total FAs increased 11% (P = 0.009) and 20% (P = 0.005), respectively. Increased palmitic acid and total FA suggest that LPC provided by the product created an intraluminal environment that increased coingested dietary fat absorption and provided more calories. This trial was registered at clinicaltrials.gov as NCT00406536.

Keywords: cystic fibrosis; enteral nutrition; fat absorption; fatty acids; lipids; malnutrition.

PubMed Disclaimer

References

    1. Guenter P., Abdelhadi R., Anthony P., Blackmer A., Malone A., Mirtallo J.M., et al. Malnutrition diagnoses and associated outcomes in hospitalized patients: United States, 2018, Nutr. Clin. Pract. 2021;36(5):957–969. doi: 10.1002/ncp.10771. - DOI - PubMed
    1. Carvalho-Salemi J., Phillips W., Wong Vega M., Swanson J., Becker P.J., Salemi J.L. Malnutrition among hospitalized children in the United States: a 2012-2019 update of annual trends. J. Acad. Nutr. Diet. 2023;123(1):109–116. doi: 10.1016/j.jand.2022.05.021. - DOI - PubMed
    1. Bellanti F., Lo Buglio A., Quiete S., Vendemiale G. Malnutrition in hospitalized old patients: screening and diagnosis, clinical outcomes, and management. Nutrients. 2022;14(4):910. doi: 10.3390/nu14040910. - DOI - PMC - PubMed
    1. Schall J.I., Mascarenhas M.R., Maqbool A., Dougherty K.A., Elci O., Wang D.J., et al. Choline supplementation with a structured lipid in children with cystic fibrosis: a randomized placebo-controlled trial. J. Pediatr. Gastroenterol. Nutr. 2016;62(4):618–626. doi: 10.1097/MPG.0000000000001004. - DOI - PMC - PubMed
    1. Stallings V.A., Schall J.I., Maqbool A., Mascarenhas M.R., Alshaikh B.N., Dougherty K.A., et al. Effect of oral lipid matrix supplement on fat absorption in cystic fibrosis: a randomized placebo-controlled trial. J. Pediatr. Gastroenterol. Nutr. 2016;63(6):676–680. doi: 10.1097/MPG.0000000000001213. - DOI - PMC - PubMed

Publication types

Associated data